Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut STAC3 246329 broad.mit.edu 37 12 57642553 57642553 + Missense_Mutation SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr12:57642553C>T ENST00000332782.2 - 4 569 c.368G>A c.(367-369)tGc>tAc p.C123Y STAC3_ENST00000546246.2_Intron|STAC3_ENST00000554578.1_Missense_Mutation_p.C84Y NM_145064.1 NP_659501.1 Q96MF2 STAC3_HUMAN SH3 and cysteine rich domain 3 123 intracellular signal transduction identical protein binding|metal ion binding breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(1)|lung(10)|ovary(2)|skin(1) 18 GTTGGTTTTGCAGTTCTTACA 0.488000 5 365 0 0 1 0 0 IL13RA1 3597 broad.mit.edu 37 X 117875042 117875042 + Missense_Mutation SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chrX:117875042A>G ENST00000371666.3 + 2 218 c.151A>G c.(151-153)Aca>Gca p.T51A IL13RA1_ENST00000371642.1_Missense_Mutation_p.T51A NM_001560.2 NP_001551.1 P78552 I13R1_HUMAN interleukin 13 receptor, alpha 1 51 interleukin-13 receptor complex cytokine receptor activity endometrium(2)|kidney(1)|large_intestine(2)|lung(7) 12 AGTAATATGGACATGGAATCC 0.378000 8 42 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7577547 7577547 + Missense_Mutation SNP C C A rs121912656 TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr17:7577547C>A ENST00000420246.2 - 7 866 c.734G>T c.(733-735)gGc>gTc p.G245V TP53_ENST00000445888.2_Missense_Mutation_p.G245V|TP53_ENST00000359597.4_Missense_Mutation_p.G245V|TP53_ENST00000269305.4_Missense_Mutation_p.G245V|TP53_ENST00000413465.2_Missense_Mutation_p.G245V|TP53_ENST00000455263.2_Missense_Mutation_p.G245V NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 245 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain. G -> A (in sporadic cancers; somatic mutation).|G -> C (in LFS; germline mutation and in sporadic cancers; somatic mutation).|G -> D (in LFS; germline mutation and in sporadic cancers; somatic mutation).|G -> E (in a sporadic cancer; somatic mutation).|G -> F (in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions).|G -> H (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|G -> L (in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions).|G -> N (in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions).|G -> R (in sporadic cancers; somatic mutation).|G -> S (in LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934575).|G -> V (in LFS; germline mutation and in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.G245D(104)|p.G245V(66)|p.G245A(8)|p.0?(8)|p.?(5)|p.G152V(4)|p.G244_M246>V(3)|p.G152D(3)|p.G245N(2)|p.G245H(1)|p.G245L(1)|p.G244fs*17(1)|p.G245F(1)|p.G245E(1)|p.C242_M246>L(1)|p.G245fs*2(1)|p.S241_G245delSCMGG(1)|p.C242fs*98(1)|p.M243fs*18(1)|p.C238_M246delCNSSCMGGM(1)|p.G151_M153>V(1)|p.G245del(1)|p.G245fs*14(1)|p.G245fs*17(1)|p.G245fs*16(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CCGGTTCATGCCGCCCATGCA 0.582000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 19 15 1.22574e-08 1.25887e-08 1 1 0 DCUN1D4 23142 broad.mit.edu 37 4 52777312 52777312 + Missense_Mutation SNP T T C TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr4:52777312T>C ENST00000334635.5 + 9 872 c.692T>C c.(691-693)cTt>cCt p.L231P DCUN1D4_ENST00000381441.3_Intron|DCUN1D4_ENST00000381437.4_Missense_Mutation_p.L171P|DCUN1D4_ENST00000451288.2_Missense_Mutation_p.L275P NM_001040402.1 NP_001035492.1 Q92564 DCNL4_HUMAN DCN1, defective in cullin neddylation 1, domain containing 4 231 DCUN1. endometrium(2)|large_intestine(2)|lung(2)|ovary(2)|skin(1) 9 GBM - Glioblastoma multiforme(4;1.93e-11)|LUSC - Lung squamous cell carcinoma(32;0.00654) ATCTGGCCCCTTTTTCCAGTT 0.383000 3 49 0 0 1 0 0 NRXN3 9369 broad.mit.edu 37 14 79433549 79433549 + Splice_Site SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr14:79433549A>G ENST00000554719.1 + 10 2149 c.e10-1 NRXN3_ENST00000335750.5_Splice_Site NM_004796.4 NP_004787.2 Q9HDB5 NRX3B_HUMAN neurexin 3 angiogenesis|cell adhesion integral to membrane NS(1)|breast(4)|central_nervous_system(1)|endometrium(6)|kidney(2)|large_intestine(23)|lung(40)|ovary(3)|pancreas(2)|prostate(5)|skin(7)|upper_aerodigestive_tract(9)|urinary_tract(1) 104 Renal(4;0.00876) BRCA - Breast invasive adenocarcinoma(234;0.00544)|Kidney(3;0.029)|KIRC - Kidney renal clear cell carcinoma(182;0.223) TTTTCTTCCTAGGTATATACA 0.423000 7 16 0 0 1 0 0 BTBD7 55727 broad.mit.edu 37 14 93730194 93730194 + Silent SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr14:93730194C>T ENST00000334746.5 - 4 1615 c.1308G>A c.(1306-1308)tcG>tcA p.S436S BTBD7_ENST00000393170.2_Intron|BTBD7_ENST00000554565.1_Silent_p.S85S NM_001002860.2 NP_001002860.2 Q9P203 BTBD7_HUMAN BTB (POZ) domain containing 7 436 breast(1)|endometrium(3)|kidney(3)|large_intestine(9)|lung(8)|ovary(1)|pancreas(1)|skin(8)|upper_aerodigestive_tract(1) 35 all_cancers(154;0.08) Epithelial(152;0.196)|COAD - Colon adenocarcinoma(157;0.212)|all cancers(159;0.223) AAAAAACATCCGAAGTCATGA 0.423000 19 58 0 0 1 0 0 GLUD1P2 0 broad.mit.edu 37 10 48968566 48968566 + RNA SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr10:48968566A>G ENST00000594520.1 + 0 723 ACAGGATAACAAACTGGAAAA 0.318000 5 45 0 0 1 0 0 ITIH1 3697 broad.mit.edu 37 3 52822010 52822010 + Silent SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr3:52822010C>T ENST00000273283.2 + 17 1957 c.1933C>T c.(1933-1935)Ctg>Ttg p.L645L ITIH1_ENST00000405128.3_Silent_p.L11L|ITIH1_ENST00000542827.1_Intron|ITIH1_ENST00000540715.1_Silent_p.L503L|ITIH1_ENST00000537050.1_Silent_p.L357L NM_002215.3 NP_002206.2 P19827 ITIH1_HUMAN inter-alpha-trypsin inhibitor heavy chain 1 645 Hyaluronan-binding. hyaluronan metabolic process|leukocyte activation extracellular region calcium ion binding|serine-type endopeptidase inhibitor activity NS(1)|breast(1)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(16)|lung(18)|ovary(4)|prostate(3)|skin(3)|stomach(1)|upper_aerodigestive_tract(1) 52 BRCA - Breast invasive adenocarcinoma(193;7.04e-05)|Kidney(197;0.000659)|KIRC - Kidney renal clear cell carcinoma(197;0.000795)|OV - Ovarian serous cystadenocarcinoma(275;0.0498) AGCGTTCGTGCTGTCAGCCTT 0.607000 34 58 0 0 1 0 0 TCP10 6953 broad.mit.edu 37 6 167796320 167796320 + Silent SNP G G A TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:167796320G>A ENST00000366827.2 - 2 253 c.42C>T c.(40-42)gaC>gaT p.D14D TCP10_ENST00000397829.4_Silent_p.D14D|TCP10_ENST00000476779.2_Silent_p.D14D Q12799 TCP10_HUMAN t-complex 10 41 cytosol NS(1)|breast(1)|central_nervous_system(1)|endometrium(2)|kidney(5)|large_intestine(2)|lung(6) 18 Breast(66;1.53e-05)|Ovarian(120;0.024) OV - Ovarian serous cystadenocarcinoma(33;4.05e-20)|BRCA - Breast invasive adenocarcinoma(81;1.1e-06)|GBM - Glioblastoma multiforme(31;0.0386) CGGCATTGCTGTCCTCCCTGG 0.652000 3 8 0 0 1 0 0 TNRC18 84629 broad.mit.edu 37 7 5402311 5402311 + Missense_Mutation SNP C C G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr7:5402311C>G ENST00000399537.4 - 12 4713 c.4365G>C c.(4363-4365)aaG>aaC p.K1455N TNRC18_ENST00000430969.1_Missense_Mutation_p.K1455N O15417 TNC18_HUMAN trinucleotide repeat containing 18 1455 DNA binding central_nervous_system(1)|endometrium(1)|large_intestine(1)|lung(8) 11 Ovarian(82;0.142) UCEC - Uterine corpus endometrioid carcinoma (126;0.195)|OV - Ovarian serous cystadenocarcinoma(56;5.32e-15) TCCAGCTGTACTTCTTGTTGG 0.677000 4 1 0 0 1 0 0 ANXA10 11199 broad.mit.edu 37 4 169100462 169100462 + Splice_Site SNP T T C TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr4:169100462T>C ENST00000359299.3 + 9 909 c.724_splice c.e9+1 p.I241_splice NM_007193.4 NP_009124.2 Q9UJ72 ANX10_HUMAN annexin A10 241 calcium ion binding|calcium-dependent phospholipid binding endometrium(1)|kidney(2)|large_intestine(4)|lung(6)|prostate(1)|stomach(2) 16 Prostate(90;0.00876)|Renal(120;0.0183)|all_neural(102;0.0837)|Melanoma(52;0.132) GBM - Glioblastoma multiforme(119;0.0325) TGGTTGCAATTGGTAAGTAAT 0.338000 6 2 0 0 1 0 0 SLC9A4 389015 broad.mit.edu 37 2 103141552 103141552 + Missense_Mutation SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr2:103141552C>T ENST00000295269.4 + 10 2345 c.1888C>T c.(1888-1890)Cgc>Tgc p.R630C NM_001011552.3 NP_001011552.2 Q6AI14 SL9A4_HUMAN solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 630 regulation of pH apical plasma membrane|basolateral plasma membrane|integral to membrane sodium:hydrogen antiporter activity NS(1)|autonomic_ganglia(1)|central_nervous_system(1)|cervix(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(8)|lung(16)|ovary(1)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 43 GATTCTGATCCGCCGCCAGAA 0.502000 5 150 0 0 1 0 0 MARCH10 162333 broad.mit.edu 37 17 60802387 60802387 + Silent SNP G G A TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr17:60802387G>A ENST00000544856.2 - 8 2391 c.2013C>T c.(2011-2013)ccC>ccT p.P671P RP11-156L14.1_ENST00000579201.1_RNA|MARCH10_ENST00000311269.5_Silent_p.P672P|RP11-156L14.1_ENST00000577270.1_RNA|MARCH10_ENST00000583600.1_Silent_p.P710P|RP11-156L14.1_ENST00000582564.1_RNA|RP11-156L14.1_ENST00000584597.1_RNA|MARCH10_ENST00000456609.2_Silent_p.P672P Q8NA82 MARHA_HUMAN membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase 672 ligase activity|zinc ion binding breast(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(11)|liver(1)|lung(15) 38 GCTCCAGGAGGGGGTTGCTTG 0.537000 31 43 0 0 1 0 0 WNT7A 7476 broad.mit.edu 37 3 13896294 13896294 + Missense_Mutation SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr3:13896294C>T ENST00000285018.4 - 3 609 c.305G>A c.(304-306)cGg>cAg p.R102Q NM_004625.3 NP_004616.2 O00755 WNT7A_HUMAN wingless-type MMTV integration site family, member 7A 102 activation of JUN kinase activity|anterior/posterior pattern formation|canonical Wnt receptor signaling pathway|cell proliferation in forebrain|cellular response to transforming growth factor beta stimulus|central nervous system vasculogenesis|cerebellar granule cell differentiation|dorsal/ventral pattern formation|embryonic axis specification|embryonic digit morphogenesis|embryonic forelimb morphogenesis|embryonic leg morphogenesis|lens fiber cell development|negative regulation of neurogenesis|palate development|positive regulation of canonical Wnt receptor signaling pathway|positive regulation of epithelial cell proliferation involved in wound healing|positive regulation of JNK cascade|positive regulation of synaptogenesis|positive regulation of transcription from RNA polymerase II promoter|regulation of axon diameter|satellite cell activation|satellite cell maintenance involved in skeletal muscle regeneration|sex differentiation|uterus development|Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells|Wnt receptor signaling pathway, calcium modulating pathway extracellular space|plasma membrane|proteinaceous extracellular matrix cytokine activity|frizzled binding|receptor agonist activity|signal transducer activity NS(1)|breast(2)|endometrium(1)|kidney(1)|large_intestine(2)|lung(11)|ovary(3)|skin(2)|upper_aerodigestive_tract(1) 24 CGCAGCCTCCCGGCTCCCTGC 0.622000 9 37 0 0 1 0 0 SNX9 51429 broad.mit.edu 37 6 158357011 158357011 + Missense_Mutation SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:158357011A>G ENST00000392185.3 + 14 1553 c.1382A>G c.(1381-1383)aAt>aGt p.N461S NM_016224.3 NP_057308.1 Q9Y5X1 SNX9_HUMAN sorting nexin 9 461 BAR. cell communication|intracellular protein transport|lipid tube assembly|positive regulation of GTPase activity|positive regulation of protein oligomerization|receptor-mediated endocytosis clathrin-coated vesicle|cytoplasmic vesicle membrane|extrinsic to internal side of plasma membrane|ruffle|trans-Golgi network 1-phosphatidylinositol binding|protein homodimerization activity|ubiquitin protein ligase binding central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(3)|lung(10)|skin(1)|upper_aerodigestive_tract(1) 20 Breast(66;0.000776)|Ovarian(120;0.0303)|Prostate(117;0.167) OV - Ovarian serous cystadenocarcinoma(65;8.06e-18)|BRCA - Breast invasive adenocarcinoma(81;4.48e-05) ACAGATCTCAATGATGCAATA 0.303000 10 20 0 0 1 0 0 C20orf26 26074 broad.mit.edu 37 20 20269322 20269322 + Missense_Mutation SNP G G T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr20:20269322G>T ENST00000245957.5 + 23 2942 c.2866G>T c.(2866-2868)Gtg>Ttg p.V956L C20orf26_ENST00000377309.2_Intron NM_015585.3 NP_056400.3 Q8NHU2 CT026_HUMAN chromosome 20 open reading frame 26 956 NS(2)|breast(3)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(11)|lung(42)|ovary(3)|pancreas(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1) 77 READ - Rectum adenocarcinoma(2;0.171) TGCATGTCTTGTGTATGACAG 0.418000 60 106 3.13765e-25 3.31197e-25 1 1 0 RBM12 10137 broad.mit.edu 37 20 34240878 34240878 + Silent SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr20:34240878A>G ENST00000374114.3 - 3 2630 c.2367T>C c.(2365-2367)ccT>ccC p.P789P RBM12_ENST00000359646.1_Silent_p.P789P|CPNE1_ENST00000352393.4_Intron|CPNE1_ENST00000397442.1_Intron|RBM12_ENST00000374104.3_Silent_p.P789P|CPNE1_ENST00000397443.1_Intron|CPNE1_ENST00000317619.3_Intron|CPNE1_ENST00000397445.1_Intron|CPNE1_ENST00000397446.1_Intron|CPNE1_ENST00000317677.5_Intron NM_001198838.1|NM_001198840.1|NM_006047.5 NP_001185767.1|NP_001185769.1|NP_006038.2 Q9NTZ6 RBM12_HUMAN RNA binding motif protein 12 789 Gly-rich.|Pro-rich. nucleus nucleotide binding|protein binding|RNA binding breast(3)|endometrium(7)|kidney(1)|large_intestine(3)|lung(14)|ovary(3)|skin(1)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1) 36 Lung NSC(9;0.00608)|all_lung(11;0.00918) BRCA - Breast invasive adenocarcinoma(18;0.00953) CAAAATTCTGAGGGCCCCCTC 0.572000 3 34 0 0 1 0 0 IDH1 3417 broad.mit.edu 37 2 209113113 209113113 + Missense_Mutation SNP G G A rs121913499 TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr2:209113113G>A ENST00000415913.1 - 4 775 c.394C>T c.(394-396)Cgt>Tgt p.R132C IDH1_ENST00000345146.2_Missense_Mutation_p.R132C|IDH1_ENST00000446179.1_Missense_Mutation_p.R132C O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132C(446)|p.R132G(125)|p.R132S(106)|p.G131_R132>VL(1)|p.R132V(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) TAAGCATGACGACCTATGATG 0.398000 Mis gliobastoma 15 29 0 0 1 0 0 LRP8 7804 broad.mit.edu 37 1 53736990 53736990 + Silent SNP G G A TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr1:53736990G>A ENST00000306052.6 - 7 1136 c.1035C>T c.(1033-1035)ggC>ggT p.G345G LRP8_ENST00000354412.3_Silent_p.G216G|LRP8_ENST00000347547.2_Silent_p.G175G|LRP8_ENST00000465675.1_5'UTR|LRP8_ENST00000371454.2_Silent_p.G345G NM_004631.4 NP_004622.2 Q14114 LRP8_HUMAN low density lipoprotein receptor-related protein 8, apolipoprotein e receptor 345 EGF-like 1. cytokine-mediated signaling pathway|endocytosis|lipid metabolic process|platelet activation|proteolysis caveola calcium ion binding|very-low-density lipoprotein particle receptor activity endometrium(2)|kidney(1)|large_intestine(6)|lung(9)|prostate(2)|skin(1) 21 GTGAGCAGCCGCCATTGTTGT 0.612000 5 59 0 0 1 0 0 ATN1 1822 broad.mit.edu 37 12 7045239 7045239 + Missense_Mutation SNP C C G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr12:7045239C>G ENST00000356654.4 + 5 1046 c.809C>G c.(808-810)gCt>gGt p.A270G ATN1_ENST00000396684.2_Missense_Mutation_p.A270G NM_001007026.1 NP_001007027.1 P54259 ATN1_HUMAN atrophin 1 270 cell death|central nervous system development cytoplasm|nucleus protein domain specific binding breast(5)|central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(4)|lung(15)|ovary(2)|pancreas(1)|prostate(1)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(2) 40 GCTAGTGGTGCTCCCCCAACA 0.627000 9 27 0 0 1 0 0 SNHG14 0 broad.mit.edu 37 15 25415763 25415763 + RNA SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr15:25415763C>T ENST00000549301.1 + 0 277 SNHG14_ENST00000553149.1_RNA GCCCCCGGTGCGCTGAAGCTC 0.657000 10 20 0 0 1 0 0 MAN1C1 57134 broad.mit.edu 37 1 26104708 26104708 + Missense_Mutation SNP G G A TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr1:26104708G>A ENST00000374332.4 + 9 1700 c.1370G>A c.(1369-1371)gGc>gAc p.G457D MAN1C1_ENST00000374329.1_Missense_Mutation_p.G228D|MAN1C1_ENST00000263979.3_Missense_Mutation_p.G277D NM_020379.2 NP_065112.1 Q9NR34 MA1C1_HUMAN mannosidase, alpha, class 1C, member 1 457 post-translational protein modification|protein N-linked glycosylation via asparagine integral to Golgi membrane calcium ion binding|mannosyl-oligosaccharide 1,2-alpha-mannosidase activity NS(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(8)|lung(7)|pancreas(1)|prostate(1)|skin(2) 25 Colorectal(325;3.78e-05)|Lung NSC(340;0.000181)|all_lung(284;0.000245)|Renal(390;0.000714)|Ovarian(437;0.00159)|Breast(348;0.0156)|Myeloproliferative disorder(586;0.0257)|all_neural(195;0.0515)|Esophageal squamous(538;0.232) UCEC - Uterine corpus endometrioid carcinoma (279;0.0574)|OV - Ovarian serous cystadenocarcinoma(117;2.46e-25)|Colorectal(126;1.15e-07)|COAD - Colon adenocarcinoma(152;4.31e-06)|STAD - Stomach adenocarcinoma(196;0.00125)|BRCA - Breast invasive adenocarcinoma(304;0.00141)|KIRC - Kidney renal clear cell carcinoma(1967;0.00146)|GBM - Glioblastoma multiforme(114;0.0149)|READ - Rectum adenocarcinoma(331;0.0803) TTCTCCGGGGGCATGATCGCC 0.612000 18 21 0 0 1 0 0 HLA-A 3105 broad.mit.edu 37 6 29910693 29910693 + Missense_Mutation SNP A A G rs41559716 by1000genomes TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:29910693A>G ENST00000396634.1 + 4 574 c.233A>G c.(232-234)cAg>cGg p.Q78R HLA-A_ENST00000376809.5_Missense_Mutation_p.Q78R|HLA-A_ENST00000376802.2_Missense_Mutation_p.Q78R|HLA-A_ENST00000376806.5_Missense_Mutation_p.Q78R P30443 1A01_HUMAN major histocompatibility complex, class I, A 78 Alpha-1. antigen processing and presentation of peptide antigen via MHC class I|interferon-gamma-mediated signaling pathway|interspecies interaction between organisms|regulation of immune response|type I interferon-mediated signaling pathway integral to plasma membrane|MHC class I protein complex MHC class I receptor activity p.Q78R(2) central_nervous_system(2)|cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(10)|ovary(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(5)|urinary_tract(2) 30 TGGATAGAGCAGGAGGGGCCG 0.657000 Osteosarcoma, Familial Clustering of;Naso-/Oropharyngeal/Laryngeal Cancer, Familial Clustering of;Melanoma, Familial Clustering of;Lichen Sclerosis et Atrophicus, Familial Clustering of Multiple Myeloma(9;0.094) 3 13 0 0 1 0 0 SNX31 169166 broad.mit.edu 37 8 101612660 101612660 + Missense_Mutation SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr8:101612660C>T ENST00000311812.2 - 9 841 c.691G>A c.(691-693)Gac>Aac p.D231N SNX31_ENST00000428383.2_Missense_Mutation_p.D132N NM_152628.3 NP_689841.3 Q8N9S9 SNX31_HUMAN sorting nexin 31 231 cell communication|protein transport phosphatidylinositol binding NS(1)|breast(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(12)|prostate(1)|skin(3)|urinary_tract(1) 26 all_cancers(14;4.01e-05)|all_epithelial(15;1.26e-07)|Lung NSC(17;0.000453)|all_lung(17;0.00125) Epithelial(11;1.21e-11)|all cancers(13;2.62e-09)|OV - Ovarian serous cystadenocarcinoma(57;3.22e-06)|STAD - Stomach adenocarcinoma(118;0.206) TTTTCAATGTCCTGTATTGCC 0.348000 38 80 0 0 1 0 0 GATA6 2627 broad.mit.edu 37 18 19751274 19751274 + Missense_Mutation SNP G G A TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr18:19751274G>A ENST00000269216.3 + 2 446 c.169G>A c.(169-171)Gcc>Acc p.A57T GATA6_ENST00000581694.1_Missense_Mutation_p.A57T NM_005257.4 NP_005248.2 Q92908 GATA6_HUMAN GATA binding protein 6 57 blood coagulation|cardiac vascular smooth muscle cell differentiation|cellular response to hypoxia|intestinal epithelial cell differentiation|male gonad development|negative regulation of apoptosis|negative regulation of transcription from RNA polymerase II promoter|negative regulation of transforming growth factor-beta1 production|negative regulation of transforming growth factor-beta2 production|outflow tract septum morphogenesis|positive regulation of angiogenesis|positive regulation of cell cycle arrest|positive regulation of transcription from RNA polymerase II promoter|response to drug|response to growth factor stimulus protein binding|protein kinase binding|sequence-specific DNA binding transcription factor activity|transcription factor binding|transcription regulatory region DNA binding|zinc ion binding NS(1)|central_nervous_system(3)|endometrium(2)|large_intestine(2)|lung(8)|prostate(1)|skin(1) 18 all_cancers(21;0.00271)|all_epithelial(16;7.31e-05)|Ovarian(2;0.116)|Lung NSC(20;0.123)|all_lung(20;0.246) STAD - Stomach adenocarcinoma(5;0.106) CCCCGGCGGCGCCAGCAACTG 0.741000 4 3 0 0 1 0 0 PHF3 23469 broad.mit.edu 37 6 64408211 64408211 + Missense_Mutation SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:64408211A>G ENST00000262043.3 + 7 3119 c.2779A>G c.(2779-2781)Atc>Gtc p.I927V PHF3_ENST00000393387.1_Missense_Mutation_p.I927V Q92576 PHF3_HUMAN PHD finger protein 3 927 TFIIS central. multicellular organismal development|transcription, DNA-dependent nucleus zinc ion binding breast(7)|cervix(2)|endometrium(8)|kidney(7)|large_intestine(18)|lung(21)|ovary(3)|prostate(1)|skin(2)|upper_aerodigestive_tract(6) 75 all_cancers(3;0.0241)|all_epithelial(2;0.00306)|Lung NSC(77;0.121) LUSC - Lung squamous cell carcinoma(74;0.0644)|Lung(124;0.148) TGCAGATCAGATCAGGCAAAG 0.343000 44 109 0 0 1 0 0 PKHD1 5314 broad.mit.edu 37 6 51484035 51484035 + Silent SNP G G A TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:51484035G>A ENST00000371117.3 - 67 12344 c.12069C>T c.(12067-12069)gaC>gaT p.D4023D RP3-335N17.2_ENST00000589278.1_RNA|RP3-335N17.2_ENST00000454361.1_RNA NM_138694.3 NP_619639.3 P08F94 PKHD1_HUMAN polycystic kidney and hepatic disease 1 (autosomal recessive) 4023 cell-cell adhesion|cilium assembly|homeostatic process|kidney development|negative regulation of cellular component movement anchored to external side of plasma membrane|apical plasma membrane|integral to membrane|microtubule basal body protein binding|receptor activity NS(1)|autonomic_ganglia(1)|breast(8)|central_nervous_system(5)|cervix(1)|endometrium(16)|haematopoietic_and_lymphoid_tissue(4)|kidney(11)|large_intestine(59)|lung(139)|ovary(16)|prostate(8)|skin(20)|soft_tissue(1)|stomach(2)|upper_aerodigestive_tract(7)|urinary_tract(5) 304 Lung NSC(77;0.0605) CTTGTCTGAAGTCTGGGCATA 0.567000 10 23 0 0 1 0 0 MUC16 94025 broad.mit.edu 37 19 9048095 9048095 + Missense_Mutation SNP G G T rs72486386 by1000genomes TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr19:9048095G>T ENST00000397910.4 - 5 33739 c.33536C>A c.(33535-33537)aCc>aAc p.T11179N NM_024690.2 NP_078966.2 Q8WXI7 MUC16_HUMAN mucin 16, cell surface associated 11181 Thr-rich. cell adhesion extracellular space|extrinsic to membrane|integral to membrane|plasma membrane protein binding NS(9)|autonomic_ganglia(1)|breast(26)|central_nervous_system(11)|cervix(1)|endometrium(46)|haematopoietic_and_lymphoid_tissue(5)|kidney(35)|large_intestine(91)|liver(1)|lung(278)|ovary(17)|pancreas(2)|prostate(17)|skin(18)|soft_tissue(1)|stomach(8)|upper_aerodigestive_tract(16)|urinary_tract(7) 590 TGAAGTTGTGGTCTCTGGTTC 0.468000 3 27 1 1 1 1 0 OR5AP2 338675 broad.mit.edu 37 11 56409457 56409457 + Silent SNP G G C TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr11:56409457G>C ENST00000544374.1 - 1 490 c.462C>G c.(460-462)acC>acG p.T154T OR5AP2_ENST00000302981.1_Silent_p.T153T Q8NGF4 O5AP2_HUMAN olfactory receptor, family 5, subfamily AP, member 2 153 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity breast(2)|central_nervous_system(2)|endometrium(1)|kidney(2)|large_intestine(5)|liver(1)|lung(11)|ovary(1)|skin(2)|upper_aerodigestive_tract(2) 29 CTAAGAAGGAGGTAGCTATTA 0.453000 10 33 0 0 1 0 0 VGLL2 245806 broad.mit.edu 37 6 117591791 117591791 + Silent SNP C C T TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:117591791C>T ENST00000326274.5 + 3 667 c.477C>T c.(475-477)ggC>ggT p.G159G VGLL2_ENST00000352536.3_Intron NM_182645.2 NP_872586.1 Q8N8G2 VGLL2_HUMAN vestigial like 2 (Drosophila) 159 transcription, DNA-dependent nucleus central_nervous_system(1)|kidney(1)|lung(3) 5 GBM - Glioblastoma multiforme(226;0.0254)|all cancers(137;0.0676)|OV - Ovarian serous cystadenocarcinoma(136;0.0757) CGCCGCTGGGCAGCCCTCTGG 0.741000 4 3 0 0 1 0 0 YIPF3 25844 broad.mit.edu 37 6 43480227 43480227 + Silent SNP G G A rs147670761 by1000genomes TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr6:43480227G>A ENST00000372422.2 - 8 1037 c.855C>T c.(853-855)caC>caT p.H285H YIPF3_ENST00000506469.1_Silent_p.H291H NM_015388.3 NP_056203.2 Q9GZM5 YIPF3_HUMAN Yip1 domain family, member 3 285 cell differentiation integral to membrane|plasma membrane|transport vesicle large_intestine(2)|lung(4)|pancreas(1)|prostate(1)|skin(1) 9 all_cancers(18;3.79e-05)|Lung NSC(15;0.00217)|all_lung(25;0.00536) Colorectal(64;0.00245)|COAD - Colon adenocarcinoma(64;0.00536)|all cancers(41;0.00736)|OV - Ovarian serous cystadenocarcinoma(102;0.0711) GGAAGAGCATGTGTAGGGCAG 0.567000 7 6 0 0 1 0 0 SF3B2 10992 broad.mit.edu 37 11 65829467 65829467 + Missense_Mutation SNP G G C TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr11:65829467G>C ENST00000528302.1 + 15 1978 c.1924G>C c.(1924-1926)Gag>Cag p.E642Q SF3B2_ENST00000322535.6_Missense_Mutation_p.E659Q Q13435 SF3B2_HUMAN splicing factor 3b, subunit 2, 145kDa 659 interspecies interaction between organisms catalytic step 2 spliceosome|nucleoplasm|U12-type spliceosomal complex nucleic acid binding|protein binding breast(3)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(8)|liver(2)|lung(14)|ovary(2)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(2) 41 GCCCATCCCTGAGGTGAGCAT 0.498000 3 7 0 0 1 0 0 VWA2 340706 broad.mit.edu 37 10 116038488 116038488 + Silent SNP C C G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr10:116038488C>G ENST00000603594.1 + 8 1032 c.711C>G c.(709-711)gtC>gtG p.V237V VWA2_ENST00000392982.3_Silent_p.V237V NM_001272046.1 NP_001258975.1 Q5GFL6 VWA2_HUMAN von Willebrand factor A domain containing 2 237 extracellular region central_nervous_system(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(7)|lung(6)|ovary(2)|prostate(1)|skin(1)|stomach(1) 26 Epithelial(162;0.036)|all cancers(201;0.0793) ACTGCAGGGTCGAGGCTCACC 0.657000 17 15 0 0 1 0 0 CSPP1 79848 broad.mit.edu 37 8 68074125 68074125 + Missense_Mutation SNP A A G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr8:68074125A>G ENST00000262210.5 + 20 2634 c.2603A>G c.(2602-2604)gAc>gGc p.D868G CSPP1_ENST00000521168.1_3'UTR|CSPP1_ENST00000412460.1_Missense_Mutation_p.D523G NM_024790.6 NP_079066.5 Q1MSJ5 CSPP1_HUMAN centrosome and spindle pole associated protein 1 903 centrosome|microtubule|spindle NS(1)|breast(3)|endometrium(4)|kidney(3)|large_intestine(11)|lung(17)|ovary(5)|prostate(3)|skin(1)|urinary_tract(1) 49 Breast(64;0.214) Lung NSC(129;0.0908)|all_lung(136;0.152) Epithelial(68;0.00145)|OV - Ovarian serous cystadenocarcinoma(28;0.00589)|all cancers(69;0.0069)|BRCA - Breast invasive adenocarcinoma(89;0.153) CCTTCAGTTGACAGCATCATA 0.343000 38 94 0 0 1 0 0 ZNF814 730051 broad.mit.edu 37 19 58385762 58385762 + Silent SNP C C G TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr19:58385762C>G ENST00000435989.2 - 3 1230 c.996G>C c.(994-996)tcG>tcC p.S332S ZNF814_ENST00000597832.1_Intron|ZNF814_ENST00000597342.1_Intron|ZNF814_ENST00000596604.1_Intron|ZNF814_ENST00000595295.1_Intron|ZNF814_ENST00000600634.1_Intron NM_001144989.1 NP_001138461.1 B7Z6K7 ZN814_HUMAN zinc finger protein 814 332 regulation of transcription, DNA-dependent intracellular nucleic acid binding|zinc ion binding p.S332S(2) NS(1)|central_nervous_system(2)|endometrium(3)|kidney(9)|lung(2)|prostate(4)|skin(1)|urinary_tract(3) 25 ATTTGCTAAACGATTTCCCAC 0.358000 2 3 0 0 1 0 0 DLG5 9231 broad.mit.edu 37 10 79685993 79685993 + Frame_Shift_Del DEL G G - TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr10:79685993delG ENST00000372391.2 - 1 291 c.286delC c.(286-288)agfs p.Q96fs DLG5_ENST00000372388.2_Frame_Shift_Del_p.Q96fs NM_004747.3 NP_004738.3 Q8TDM6 DLG5_HUMAN discs, large homolog 5 (Drosophila) 96 cell-cell adhesion|intracellular signal transduction|negative regulation of cell proliferation|regulation of apoptosis cell junction|cytoplasm beta-catenin binding|cytoskeletal protein binding|receptor signaling complex scaffold activity breast(9)|central_nervous_system(3)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(8)|lung(17)|ovary(5)|prostate(1)|skin(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(2) 60 all_cancers(46;0.0316)|all_epithelial(25;0.00147)|Breast(12;0.0015)|Prostate(51;0.0146) Epithelial(14;0.00105)|OV - Ovarian serous cystadenocarcinoma(4;0.00151)|all cancers(16;0.00446) TCGGCGGGCTGCGGCGGCCCG 0.726 2 4 --- --- --- --- SIK2 23235 broad.mit.edu 37 11 111594198 111594221 + Splice_Site DEL TCCTTTGATATTACCAATTTAGGC TCCTTTGATATTACCAATTTAGGC - TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr11:111594198_111594221delTCCTTTGATATTACCAATTTAGGC ENST00000304987.3 + 15 2320_2322 c.2147_splice c.e15-1 p.I716_splice NM_015191.1 NP_056006.1 Q9H0K1 SIK2_HUMAN salt-inducible kinase 2 716 intracellular protein kinase cascade|regulation of insulin receptor signaling pathway Golgi apparatus ATP binding|magnesium ion binding|protein binding|protein serine/threonine kinase activity breast(1)|central_nervous_system(2)|cervix(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(5)|lung(7)|prostate(3)|skin(1)|upper_aerodigestive_tract(3) 30 TAAAATTCTTTCCTTTGATATTACCAATTTAGGCTCCAGCAGAA 0.402 9 31 --- --- --- --- DHRS4L1 728635 broad.mit.edu 37 14 24511654 24511656 + RNA DEL TTG TTG - TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chr14:24511654_24511656delTTG ENST00000558293.1 + 0 437 NR_102693.1 dehydrogenase/reductase (SDR family) member 4 like 1 GAAGGAAGATttgttgttgttgt 0.365 2 4 --- --- --- --- TCEANC 170082 broad.mit.edu 37 X 13681313 13681313 + Frame_Shift_Del DEL C C - TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chrX:13681313delC ENST00000380600.1 + 2 773 c.686delC c.(685-687)gcfs p.A229fs TCEANC_ENST00000490617.1_3'UTR|TCEANC_ENST00000545566.1_Frame_Shift_Del_p.A229fs|TCEANC_ENST00000544987.1_Frame_Shift_Del_p.A229fs|TCEANC_ENST00000314720.4_Frame_Shift_Del_p.A259fs Q8N8B7 TEANC_HUMAN transcription elongation factor A (SII) N-terminal and central domain containing 229 TFIIS central. regulation of transcription elongation, DNA-dependent|regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent nucleus DNA binding central_nervous_system(1)|large_intestine(5)|lung(2)|pancreas(1) 9 AGCAAAGTTGCCAATTTGAAG 0.373 2 4 --- --- --- --- ATRX 546 broad.mit.edu 37 X 76909645 76909646 + Frame_Shift_Del DEL TT TT - TCGA-S9-A6U9-01A-11D-A32B-08 TCGA-S9-A6U9-10A-01D-A329-08 Untested Somatic Phase_I WXS none Illumina GAIIx f3b7b1a9-6595-49c9-a355-1429cff9701f 8e7599d0-823a-472b-8d6c-38730ad5fd1a g.chrX:76909645_76909646delTT ENST00000373344.5 - 14 4473_4474 c.4259_4260delAA c.(4258-4260)afs p.K1420fs ATRX_ENST00000395603.3_Frame_Shift_Del_p.K1382fs|ATRX_ENST00000480283.1_5'UTR NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 1420 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) TCTTTTTCTGTTTATAGCTCCG 0.322 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 50 34 --- --- --- ---